Tingting Qin
Tiyuanbei Huanhuxi Road
Dayingmen, 300060, China
Dayingmen, 300060, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 66 publications
Integrated single-cell and bulk transcriptomic analysis reveals an epithelial cell-derived prognostic and immunotherapeutic signature with ADAM12 as a key functional regulator in non-small cell lung cancer.
Journal: Translational oncology
Published: June 30, 2026
Ivonescimab Plus Chemotherapy versus Bevacizumab Plus Chemotherapy in EGFR-Mutant Lung Adenocarcinoma After EGFR-TKI Failure: A Two-Center Retrospective Real-World Propensity Score-Matched Study.
Journal: Drug design, development and therapy
Published: June 05, 2026
Author Correction: HDAC6 facilitates LUAD progression by inducing EMT and enhancing macrophage polarization towards the M2 phenotype.
Journal: NPJ precision oncology
Published: April 14, 2026
Enhanced recovery after surgery in elective benign general gynaecological surgery: postoperative recovery outcomes and health economic value of hospitalisation costs under China's diagnosis-related group (DRG) payment system - a retrospective cohort study at a tertiary hospital.
Journal: BMJ open
Published: February 04, 2026
Effect of hypercalcemia on immune system in patients with non-small cell lung cancer.
Journal: Cytokine
Published: December 28, 2025
Multi-omics analysis identifies GINS1 as a prognostic biomarker in lung adenocarcinoma, linked to macrophage polarization and tumor cell survival.
Journal: Discover oncology
Published: November 19, 2025
Chidamide suppresses macrophage-mediated immune evasion and tumor progression in small cell lung cancer by targeting the STAT4/CCL2 signaling pathway.
Journal: Cancer biology & medicine
Published: October 24, 2025
Compressive learning scaffolds higher-order network structure to enhance human knowledge acquisition.
Journal: Nature communications
Published: September 12, 2025
HDAC6 orchestrates metastatic and immunosuppressive programs in small cell lung cancer through S100A2-TGF-β/SMAD and CSF1R signaling.
Journal: Molecular cancer
Published: September 09, 2025
Glucocorticoid and mitophagy signaling-based molecular subtyping reveals HMGA1 as a prognostic and immunotherapy biomarker in lung adenocarcinoma.
Journal: NPJ precision oncology
Published: August 29, 2025
Last Updated: 09/26/2026